• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NeoDesign:一种用于多价新抗原组合最优选择的计算工具。

NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations.

机构信息

Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae585.

DOI:10.1093/bioinformatics/btae585
PMID:39331572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11471261/
Abstract

MOTIVATION

Tumor polyvalent neoantigen mRNA vaccines are gaining prominence in immunotherapy. The design of sequences in vaccine development is crucial for enhancing both the immunogenicity and safety of vaccines. However, a major challenge lies in selecting the optimal sequences from the large pools generated by multiple peptide combinations and synonymous codons.

RESULTS

We introduce NeoDesign, a computational tool designed to tackle the challenge of sequence design. NeoDesign comprises four modules: Library Construction, Optimal Path Filtering, Linker Addition, and λ-Evaluation. It aims to identify the optimal protein sequence for tumor polyvalent neoantigen vaccines by minimizing linker usage, avoiding unexpected neoantigens and functional domains, and simplifying the structure. It also provides a preference scheme to balance mRNA stability and protein expression when designing mRNA sequences for the optimal protein sequence. This tool can potentially improve the sequence design of tumor polyvalent neoantigen mRNA vaccines, thereby significantly advancing immunotherapy strategies.

AVAILABILITY AND IMPLEMENTATION

NeoDesign is freely available on https://github.com/HuangLab-Fudan/neoDesign and https://figshare.com/projects/NeoDesign/221704.

摘要

动机

肿瘤多价新抗原 mRNA 疫苗在免疫疗法中越来越受到关注。在疫苗开发中设计序列对于提高疫苗的免疫原性和安全性至关重要。然而,一个主要的挑战在于从多个肽组合和同义密码子产生的大量库中选择最佳序列。

结果

我们引入了 NeoDesign,这是一种旨在解决序列设计挑战的计算工具。NeoDesign 由四个模块组成:文库构建、最优路径过滤、接头添加和 λ-评估。它旨在通过最小化接头使用、避免意外的新抗原和功能域以及简化结构,来确定肿瘤多价新抗原疫苗的最佳蛋白质序列。当为最优蛋白质序列设计 mRNA 序列时,它还提供了一个偏好方案来平衡 mRNA 稳定性和蛋白质表达。该工具有可能改进肿瘤多价新抗原 mRNA 疫苗的序列设计,从而显著推进免疫疗法策略。

可用性和实施

NeoDesign 可在 https://github.com/HuangLab-Fudan/neoDesign 和 https://figshare.com/projects/NeoDesign/221704 上免费获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37a/11471261/afe52b977b91/btae585f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37a/11471261/afe52b977b91/btae585f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e37a/11471261/afe52b977b91/btae585f1.jpg

相似文献

1
NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations.NeoDesign:一种用于多价新抗原组合最优选择的计算工具。
Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae585.
2
pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.pVACtools:一种用于鉴定和可视化癌症新抗原的计算工具包。
Cancer Immunol Res. 2020 Mar;8(3):409-420. doi: 10.1158/2326-6066.CIR-19-0401. Epub 2020 Jan 6.
3
Neoantigen vaccine: an emerging tumor immunotherapy.肿瘤新生抗原疫苗:一种新兴的肿瘤免疫疗法。
Mol Cancer. 2019 Aug 23;18(1):128. doi: 10.1186/s12943-019-1055-6.
4
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.新抗原鉴定策略使难治性实体瘤的个体化免疫治疗成为可能。
J Clin Invest. 2019 Mar 5;129(5):2056-2070. doi: 10.1172/JCI99538. Print 2019 May 1.
5
NeoAgDT: optimization of personal neoantigen vaccine composition by digital twin simulation of a cancer cell population.基于肿瘤细胞群体的数字孪生模拟优化个体化新生抗原疫苗组成
Bioinformatics. 2024 May 2;40(5). doi: 10.1093/bioinformatics/btae205.
6
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.pTuneos:从下一代测序数据中优先选择肿瘤新生抗原。
Genome Med. 2019 Oct 30;11(1):67. doi: 10.1186/s13073-019-0679-x.
7
Preclinical and clinical development of neoantigen vaccines.肿瘤新抗原疫苗的临床前和临床研发。
Ann Oncol. 2017 Dec 1;28(suppl_12):xii11-xii17. doi: 10.1093/annonc/mdx681.
8
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models.个性化新抗原脉冲树突状细胞疫苗在小鼠肿瘤模型中比新抗原佐剂疫苗具有更高的免疫原性。
Cancer Immunol Immunother. 2020 Jan;69(1):135-145. doi: 10.1007/s00262-019-02448-z. Epub 2019 Dec 5.
9
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.病毒样颗粒介导的结构选择新生抗原传递在小鼠中显示出免疫原性和抗肿瘤活性。
J Transl Med. 2024 Jan 3;22(1):14. doi: 10.1186/s12967-023-04843-8.
10
Cancer neoantigen: Boosting immunotherapy.癌症新生抗原:增强免疫疗法。
Biomed Pharmacother. 2020 Nov;131:110640. doi: 10.1016/j.biopha.2020.110640. Epub 2020 Aug 21.

本文引用的文献

1
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types.系统发现患者和肿瘤类型之间共享的新抗原的新表位-HLA 对。
Nat Biotechnol. 2024 Jul;42(7):1107-1117. doi: 10.1038/s41587-023-01945-y. Epub 2023 Oct 19.
2
mRNA-based cancer therapeutics.mRNA 癌症疗法。
Nat Rev Cancer. 2023 Aug;23(8):526-543. doi: 10.1038/s41568-023-00586-2. Epub 2023 Jun 13.
3
Algorithm for optimized mRNA design improves stability and immunogenicity.优化 mRNA 设计的算法可提高稳定性和免疫原性。
Nature. 2023 Sep;621(7978):396-403. doi: 10.1038/s41586-023-06127-z. Epub 2023 May 2.
4
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes.机器学习预测 MHC-II 特异性揭示了 II 类抗原表位的另一种结合模式。
Immunity. 2023 Jun 13;56(6):1359-1375.e13. doi: 10.1016/j.immuni.2023.03.009. Epub 2023 Apr 5.
5
TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.TLimmuno2:通过迁移学习预测 MHC Ⅱ类抗原免疫原性。
Brief Bioinform. 2023 May 19;24(3). doi: 10.1093/bib/bbad116.
6
RNA modification in mRNA cancer vaccines.mRNA 癌症疫苗中的 RNA 修饰。
Clin Exp Med. 2023 Oct;23(6):1917-1931. doi: 10.1007/s10238-023-01020-5. Epub 2023 Feb 14.
7
Integrated mRNA sequence optimization using deep learning.利用深度学习进行整合的 mRNA 序列优化。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbad001.
8
Neoantigens: promising targets for cancer therapy.肿瘤新抗原:癌症治疗的有前途的靶点。
Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x.
9
Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments.新抗原疫苗;临床试验、类别、适应症、佐剂及联合治疗
Cancers (Basel). 2022 Oct 21;14(20):5163. doi: 10.3390/cancers14205163.
10
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.采用化疗和抗 PD-1 药物联合治疗作为一线治疗方案,为非鳞状非小细胞肺癌患者接种个体化新抗原疫苗 NEO-PV-01。
Cancer Cell. 2022 Sep 12;40(9):1010-1026.e11. doi: 10.1016/j.ccell.2022.08.003. Epub 2022 Aug 25.